Organic nitrate tolerance is induced by degradation of some cytochrome P450 isoforms

Redox Report

Volumn 7, Issue 5, 2002, Pages 339-342

  Minamiyama, Yukiko ^a   Takemura, Shigekazu ^b   Nishino, Yoshihiro ^b   Okada, Shigeru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; CYTOCHROME P450; CYTOCHROME P450 1A2; GLYCERYL TRINITRATE; ISOENZYME; ISOSORBIDE DINITRATE; MIRISROL; NITRIC OXIDE; NITRITE; ORGANIC NITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BOLUS INJECTION; CATALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERANCE; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYTOCHROME P-450 CYP1A2; HUMANS; IMMUNOHISTOCHEMISTRY; ISOSORBIDE DINITRATE; MALE; NITRATES; NITRIC OXIDE; NITROGLYCERIN; PROTEIN ISOFORMS; RATS; RATS, WISTAR; TIME FACTORS; VASODILATOR AGENTS;

ANIMALIA;

EID: 0036924473     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100002125000947     Document Type: Article

References (16)

1. Bennett BM, McDonald BJ, Nigam R, Simon WC. Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol Sci 1994; 15: 245-249.
2. Chung SJ, Fung HL. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production. Probes with inhibitors and tolerance development. Biochem Pharmacol 1993; 45: 157-163.
3. Minamiyama Y, Takemura S, Akiyama T et al. Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Lett 1999; 452: 165-169.
4. Sage PR, de la Lande IS, Stafford I et al. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation 2000; 102: 2810-2815.
5. Meinhardt G, Sechtem U. [Development of nitrate tolerance]. Dtsch Med Wochenschr 2000; 125 (Suppl 1): S7.
6. Klemsdal TO, Gjesdal K. Intermittent or continuous transdermal nitroglycerin: still an issue, or is the case closed? Cardiovasc Drugs Ther 1996; 10: 5-10.
7. Munzel T, Mollnau H, Hartmann M et al. Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production. J Am Coll Cardiol 2000; 36: 628-634.
8. Imaoka S, Terano Y, Funae Y. Purification and characterization of two constitutive cytochromes P-450 (F-1 and F-2) from adult female rats: identification of P-450F-1 as the phenobarbital-inducible cytochrome P-450 in male rat liver. Biochim Biophys Acta 1987; 916: 358-367.
9. Minamiyama Y, Imaoka S, Takemura S, Okada S, Inoue M, Funae Y. Escape from tolerance of organic nitrate by induction of cytochrome P450. Free Radic Biol Med 2001; 31: 1498-1508.
10. Scholl HR, Iba MM. Pharmacokinetics of CYP1A induction by pyridine and acetone in the rat: interactions and effects of route of exposure. Xenobiotica 1997; 27: 265-277.
11. Barnett CR, Petrides L, Wilson J, Flatt PR, Ioannides C. Induction of rat hepatic mixed-function oxidases by acetone and other physiological ketones: their role in diabetes-induced changes in cytochrome P450 proteins. Xenobiotica 1992; 22: 1441-1450.
12. Thadani U. Nitrate therapy and the development of tolerance. Arch Fam Med 1993; 2: 880-885.
13. Gumbrielle T, Freedman SB, Fogarty L, Ogasawara S, Sobb P, Kelly DT. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina. Eur Heart J 1992; 13: 671-678.
14. Smith DA. Induction and drug development. Eur J Pharm Sci 2000; 11: 185-189.
15. Ledirac N, de Sousa G, Fontaine F et al. Effects of macrolide antibiotics on CYP3A expression in human and rat hepatocytes: interspecies differences in response to troleandomycin. Drug Metab Dispos 2000; 28: 1391-1393.
16. De Berardinis V, Moulis C, Maurice M et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000; 58: 542-551.